Concepedia

Luca Ielasi

LI

8

Publications

208

Citations

8

H-Index

2019

Active since

Affiliations

University of Bologna(Current)

Azienda Ospedaliera Universitaria Pisana

Azienda USL di Bologna

University of Modena and Reggio Emilia

Fatebenefratelli Hospital

Luca Ielasi is an author at University of Bologna specializing in oncology, hepatology, and medicine.

ORCID

Top concepts

Publications per year

2019–2024

8

Publications

8

Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients

Francesco Tovoli, Luca Ielasi, Andrea Casadei‐Gardini et al. · Journal of Hepatology · 2019 · 84 citations · Full text

, , +8

Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib

Vito Sansone, Francesco Tovoli, Andrea Casadei‐Gardini et al. · Clinical and Translational Gastroenterology · 2021 · 21 citations · Full text

Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy

Luca Ielasi, Bernardo Stefanini, Fabio Conti et al. · Current Oncology · 2024 · 21 citations · Full text

Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma

Giulia Orsi, Francesco Tovoli, Vincenzo Dadduzio et al. · Targeted Oncology · 2020 · 20 citations

, , +14

Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders

Luca Ielasi, Francesco Tovoli, Matteo Tonnini et al. · Cancers · 2021 · 20 citations · Full text

Rows per page

1–5 of 8